Literature DB >> 26940481

Complexities of Gut Microbiome Dysbiosis in the Context of HIV Infection and Antiretroviral Therapy.

S X Li1, Ajs Armstrong1,2, C P Neff1, M Shaffer1,3, C A Lozupone1, B E Palmer1.   

Abstract

Human immunodeficiency virus (HIV) infection is associated with an altered gut microbiome that is not consistently restored with effective antiretroviral therapy (ART). Interpretation of the specific microbiome changes observed during HIV infection is complicated by factors like population, sample type, and ART-each of which may have dramatic effects on gut bacteria. Understanding how these factors shape the microbiome during HIV infection (which we refer to as the HIV-associated microbiome) is critical for defining its role in HIV disease, and for developing therapies that restore gut health during infection.
© 2016 American Society for Clinical Pharmacology and Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26940481      PMCID: PMC4927263          DOI: 10.1002/cpt.363

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  73 in total

Review 1.  HIV infection and the gastrointestinal tract.

Authors:  Donald P Kotler
Journal:  AIDS       Date:  2005-01-28       Impact factor: 4.177

2.  Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals.

Authors:  J F Vázquez-Castellanos; S Serrano-Villar; A Latorre; A Artacho; M L Ferrús; N Madrid; A Vallejo; T Sainz; J Martínez-Botas; S Ferrando-Martínez; M Vera; F Dronda; M Leal; J Del Romero; S Moreno; V Estrada; M J Gosalbes; A Moya
Journal:  Mucosal Immunol       Date:  2014-11-19       Impact factor: 7.313

3.  A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes.

Authors:  Ben P Willing; Johan Dicksved; Jonas Halfvarson; Anders F Andersson; Marianna Lucio; Zongli Zheng; Gunnar Järnerot; Curt Tysk; Janet K Jansson; Lars Engstrand
Journal:  Gastroenterology       Date:  2010-10-08       Impact factor: 22.682

4.  Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota.

Authors:  June L Round; Sarkis K Mazmanian
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

5.  Plasma levels of soluble CD14 independently predict mortality in HIV infection.

Authors:  Netanya G Sandler; Handan Wand; Annelys Roque; Matthew Law; Martha C Nason; Daniel E Nixon; Court Pedersen; Kiat Ruxrungtham; Sharon R Lewin; Sean Emery; James D Neaton; Jason M Brenchley; Steven G Deeks; Irini Sereti; Daniel C Douek
Journal:  J Infect Dis       Date:  2011-01-20       Impact factor: 5.226

6.  Molecular characterization of stool microbiota in HIV-infected subjects by panbacterial and order-level 16S ribosomal DNA (rDNA) quantification and correlations with immune activation.

Authors:  Collin L Ellis; Zhong-Min Ma; Surinder K Mann; Chin-Shang Li; Jian Wu; Thomas H Knight; Tammy Yotter; Timothy L Hayes; Archana H Maniar; Paolo V Troia-Cancio; Heather A Overman; Natalie J Torok; Anthony Albanese; John C Rutledge; Christopher J Miller; Richard B Pollard; David M Asmuth
Journal:  J Acquir Immune Defic Syndr       Date:  2011-08-15       Impact factor: 3.731

7.  Geographic variation in the eukaryotic virome of human diarrhea.

Authors:  Lori R Holtz; Song Cao; Guoyan Zhao; Irma K Bauer; Donna M Denno; Eileen J Klein; Martin Antonio; O Colin Stine; Thomas L Snelling; Carl D Kirkwood; David Wang
Journal:  Virology       Date:  2014-09-28       Impact factor: 3.616

8.  Probiotic/prebiotic supplementation of antiretrovirals improves gastrointestinal immunity in SIV-infected macaques.

Authors:  Nichole R Klatt; Lauren A Canary; Xiaoyong Sun; Carol L Vinton; Nicholas T Funderburg; David R Morcock; Mariam Quiñones; Clayton B Deming; Molly Perkins; Daria J Hazuda; Michael D Miller; Michael M Lederman; Julie A Segre; Jeffrey D Lifson; Elias K Haddad; Jacob D Estes; Jason M Brenchley
Journal:  J Clin Invest       Date:  2013-01-16       Impact factor: 14.808

9.  PrEP implementation: moving from trials to policy and practice.

Authors:  Carlos F Cáceres; Kevin R O'Reilly; Kenneth H Mayer; Rachel Baggaley
Journal:  J Int AIDS Soc       Date:  2015-07-20       Impact factor: 5.396

10.  Kinetics of microbial translocation markers in patients on efavirenz or lopinavir/r based antiretroviral therapy.

Authors:  Jan Vesterbacka; Piotr Nowak; Babilonia Barqasho; Samir Abdurahman; Jessica Nyström; Staffan Nilsson; Hiroyuki Funaoka; Tatsuo Kanda; Lars-Magnus Andersson; Magnus Gisslèn; Anders Sönnerborg
Journal:  PLoS One       Date:  2013-01-28       Impact factor: 3.240

View more
  25 in total

1.  An exploration of Prevotella-rich microbiomes in HIV and men who have sex with men.

Authors:  Abigail J S Armstrong; Michael Shaffer; Nichole M Nusbacher; Christine Griesmer; Suzanne Fiorillo; Jennifer M Schneider; C Preston Neff; Sam X Li; Andrew P Fontenot; Thomas Campbell; Brent E Palmer; Catherine A Lozupone
Journal:  Microbiome       Date:  2018-11-05       Impact factor: 14.650

2.  The impact of in utero HIV exposure on gut microbiota, inflammation, and microbial translocation.

Authors:  Aline Machiavelli; Rubens T Delgado Duarte; Maria M de Souza Pires; Carlos R Zárate-Bladés; Aguinaldo R Pinto
Journal:  Gut Microbes       Date:  2019-01-18

Review 3.  Mechanisms Underlying HIV-Associated Noninfectious Lung Disease.

Authors:  Rachel M Presti; Sonia C Flores; Brent E Palmer; Jeffrey J Atkinson; Catherine R Lesko; Bryan Lau; Andrew P Fontenot; Jesse Roman; John F McDyer; Homer L Twigg
Journal:  Chest       Date:  2017-04-17       Impact factor: 9.410

4.  Mouse Subcutaneous BCG Vaccination and Mycobacterium tuberculosis Infection Alter the Lung and Gut Microbiota.

Authors:  Fabiola Silva; Raphaël Enaud; Elizabeth Creissen; Marcela Henao-Tamayo; Laurence Delhaes; Angelo Izzo
Journal:  Microbiol Spectr       Date:  2022-06-02

5.  Improvement of Gut Diversity and Composition After Direct-Acting Antivirals in Hepatitis C Virus-Infected Patients With or Without Human Immunodeficiency Virus Coinfection.

Authors:  Natthaya Chuaypen; Thananya Jinato; Anchalee Avihingsanon; Sakkarin Chirapongsathorn; Supapon Cheevadhanarak; Intawat Nookaew; Yasuhito Tanaka; Pisit Tangkijvanich
Journal:  J Infect Dis       Date:  2021-10-28       Impact factor: 5.226

6.  Altered Gut Microbiome under Antiretroviral Therapy: Impact of Efavirenz and Zidovudine.

Authors:  Shilpa Ray; Aswathy Narayanan; Christian G Giske; Ujjwal Neogi; Anders Sönnerborg; Piotr Nowak
Journal:  ACS Infect Dis       Date:  2020-12-21       Impact factor: 5.084

7.  Alcohol Use Is Associated With Intestinal Dysbiosis and Dysfunctional CD8+ T-Cell Phenotypes in Persons With Human Immunodeficiency Virus.

Authors:  Vincent J Maffei; Robert W Siggins; Meng Luo; Meghan M Brashear; Donald E Mercante; Christopher M Taylor; Patricia Molina; David A Welsh
Journal:  J Infect Dis       Date:  2021-03-29       Impact factor: 5.226

8.  Gut Microbiome, Short-Chain Fatty Acids, and Mucosa Injury in Young Adults with Human Immunodeficiency Virus Infection.

Authors:  Yong Qing; Hangyu Xie; Chen Su; Youwei Wang; Qiuyue Yu; Qiuyu Pang; Fan Cui
Journal:  Dig Dis Sci       Date:  2018-12-17       Impact factor: 3.487

9.  Alterations in the Fecal Microbiota of Patients with HIV-1 Infection: An Observational Study in A Chinese Population.

Authors:  Zongxin Ling; Changzhong Jin; Tiansheng Xie; Yiwen Cheng; Lanjuan Li; Nanping Wu
Journal:  Sci Rep       Date:  2016-08-01       Impact factor: 4.379

Review 10.  Impact of antiretroviral drugs on the microbiome: unknown answers to important questions.

Authors:  Sandra Pinto-Cardoso; Nichole R Klatt; Gustavo Reyes-Terán
Journal:  Curr Opin HIV AIDS       Date:  2018-01       Impact factor: 4.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.